Garwood Medical has now raised $11.4 million, including $3.8 million in the Series B round, which closed October 2019 and was over-subscribed by $800,000. The company raised an initial $3.6 million during the company's Series A financing round, which closed in September 2016. Funds raised will continue to support pre-clinical testing.